Press release
Comprehensive Anemia In Elderly Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034
Anemia In Elderly Market Size
Over the recent years, the market size of anemia in the elderly has experienced significant expansion. The market's value is projected to swell from $2.75 billion in 2024 to $3.02 billion in 2025, showing a compound annual growth rate (CAGR) of 9.7%. Factors such as nutritional deficiencies, chronic illnesses, inflammation, disorders of the bone marrow, and loss of blood have contributed to this growth during the historical period.
The market for anemia in the elderly is set to experience considerable growth in the coming years, ballooning to $4.32 billion in 2029 with a compound annual growth rate (CAGR) of 9.3%. Several factors are contributing to this growth during the forecasted period, including an aging demographic, an increase in chronic disease occurrence, strides in diagnostic technology, heightened awareness of healthcare needs, and enhanced treatment options. Forecasts for the period also show major trends such as diagnostics powered by AI, the use of wearable health tracking devices, sophisticated blood testing tools, the incorporation of telehealth, and individualized medicine solutions.
What Is Stimulating Growth in the Anemia In Elderly Market?
The anemia in elderly market is projected to expand due to the growth of the aging population. This population consists of an increasing ratio and count of individuals aged 65 and above, either within specific societies or on a worldwide scale. The rise in the elderly demographic is attributed to factors such as longer life expectancies, a decrease in birth rates, and the maturing of large age groups. The escalation in the number of aged individuals raises the prevalence of chronic and age-associated conditions, which are significant contributors to anemia in the elderly. This, in turn, fuels the demand for the diagnosis, management, and treatment of anemia, spurring market growth. An example of this is shown in July 2024, when the Office for National Statistics (ONS), a government agency in UK, reported that the population of individuals aged 65 or over in the UK had risen to 12.7 million in 2022, up from 11 million in 2021. Hence, the growing elderly population is propelling the anemia in elderly market's growth.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20711&type=smp
Which Key Market Leaders Are Driving Anemia In Elderly Industry Growth?
Major companies operating in the anemia in elderly market are Johnson & Johnson, Roche Holding AG, Merck & Co Inc, Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Amgen Inc, Japan Tobacco Inc, Fresenius Medical Care AG, Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, CSL Limted, Daiichi Sankyo Company Limited, Amag Pharmaceuticals, Akebia Therapeutics Inc, Pharmacosmos A/S, Rockwell Medical Inc, Bioage Labs Inc, Shield Therapeutics Plc, MegaPro Biomedical Co Ltd
What Are the Emerging Trends in the Anemia In Elderly Industry?
Significant businesses in the anemia among the elderly market are leveraging technological innovations, like tailored therapies, in an attempt to optimize treatment methodologies, boost patient results, curtail side effects, and amplify overall health care effectiveness. These personalized therapies are medical procedures tailored to an individual patient's unique attributes. For example, Cadila Pharmaceuticals, an Indian pharmaceutical organization, unveiled Redshot FCM, an innovative iron injection formulated to cure iron deficiency anemia in patients who can't tolerate oral iron, in March 2024. It's an intravenous iron supplement that effectively supplies crucial amounts of iron and maintains an exceptional safety record. The injection uses a cutting-edge Ferric Carboxymaltose formulation that enhances iron delivery and intake. Redshot FCM signifies a commitment to enhancing healthcare by creating personalized treatments that take into account individual patient characteristics, thereby resulting in improved treatment outcomes for iron deficiency anemia.
What Are the Main Segments in the Anemia In Elderly Market?
The anemia in elderly market covered in this report is segmented -
1) By Product Type: Tablets, Injectable
2) By Treatment: Iron Supplements, Erythropoietin Or Erythrocyte-Stimulating Agents, Vitamin B12 Supplements, Folic Acid Supplements
3) By Route Of Administration: Oral, Parenteral
4) By End User: Hospital pharmacy, Online Pharmacy, Retail pharmacy
Subsegments:
1) By Tablets: Iron Supplements, Vitamin B12 Supplements, Folic Acid Tablets, Erythropoiesis-Stimulating Agents (ESAs) Tablets
2) By Injectable: Iron Injections, Vitamin B12 Injections, Erythropoiesis-Stimulating Agents (ESAs) Injections, Folic Acid Injections
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/anemia-in-elderly-global-market-report
Which Geographic Area Leads the Anemia In Elderly Market?
North America was the largest region in the anemia in elderly market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anemia in elderly market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Anemia In Elderly Global Market Report?
- Market Size Analysis: Analyze the anemia in elderly Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the anemia in elderly Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall anemia in elderly market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the anemia in elderly market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20711
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Comprehensive Anemia In Elderly Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034 here
News-ID: 3875300 • Views: …
More Releases from The Business Research Company
Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additiv …
The wire arc additive manufacturing cell market is rapidly gaining traction as industries increasingly embrace advanced metal 3D printing technologies. With significant investments and technological breakthroughs, this sector is set to experience remarkable growth, transforming manufacturing processes across multiple fields. Let's explore the market's size, influential players, key trends, and segmentation to understand its future trajectory.
Projected Expansion of the Wire Arc Additive Manufacturing Cell Market
The wire arc additive manufacturing cell…
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for A …
The viscosupplementation treatment for arthritis market is on the verge of significant expansion, driven by advances in medical technology and a growing demand for effective arthritis therapies. With increasing awareness around early intervention and new treatment options, this sector is poised for rapid development over the coming years. Let's explore the market size, key players, emerging trends, and segment-wise forecasts that define this growing industry.
Projected Market Growth and Size of…
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Develop …
The viral vector development service market is set to experience substantial growth in the coming years, driven by technological progress and increasing demand from various sectors. As gene therapies and advanced treatments gain prominence, the need for efficient viral vector production and development is becoming more critical. Let's explore the market size projections, key players, emerging trends, and the segment structure shaping this industry's future.
Projected Expansion and Market Size of…
Competitive Landscape: Leading Companies and New Entrants in the Transient Elast …
The transient elastography market is poised for substantial expansion as advancements in healthcare diagnostics continue to evolve. Increasing emphasis on non-invasive techniques and early disease detection is driving widespread adoption, setting the stage for strong market growth in the coming years. Let's explore the current market valuation, leading players, emerging innovations, and key segments shaping this industry.
Projected Market Value and Growth of the Transient Elastography Market
The transient elastography market is…
More Releases for Anemia
Chemotherapy-Induced Anemia Market Forecast by Type Mild Moderate Severe and Lif …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Chemotherapy-Induced Anemia Market- (By Type of Anemia (Mild Anemia, Moderate Anemia, Severe Anemia, Life-Threatening Anemia), By Treatment Type (RBC Transfusion, Erythropoiesis-stimulating agents (ESAs), Iron Supplementation), By Drug Type (Epogen Injection, Procrit Injection, Androxy Oral, Aranesp Injection, Epoetin Alfa Injection, and Others), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)), By Region, Trends, Industry Competition…
Rising Cancer And Anemia Cases Propel Growth In Chemotherapy-Induced Anemia Mark …
The Chemotherapy-Induced Anemia Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Chemotherapy-Induced Anemia Market Size During the Forecast Period?
The Chemotherapy-Induced Anemia Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This…
Iron Deficiency Anemia Market Analysis 2034 | Iron Deficiency Anemia Therapies, …
As per DelveInsight, the Iron Deficiency Anemia Market is anticipated to grow immensely in the coming years owing to the launch of upcoming therapies and the increase in the incident population of Iron Deficiency Anemia in the 7MM.
DelveInsight's "Iron Deficiency Anemia Market Insights, Epidemiology, and Market Forecast 2034 [https://www.delveinsight.com/report-store/iron-deficiency-anemia-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Iron Deficiency Anemia market size,…
Aplastic Anemia Treatment Market - Shaping the Future of Aplastic Anemia Health: …
Newark, New Castle, USA: The "Aplastic Anemia Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Aplastic Anemia Treatment Market: https://www.growthplusreports.com/report/aplastic-anemia-treatment-market/8435
This latest report researches the industry structure,…
Anemia Drugs Market 2018 Grow at CAGR of 8.4% to Reach USD 34.7 Billion | By Uni …
Market Research Future Published a Prime research Report on “Global Anemia Drugs Market Research Report - Forecast to 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022
Global Anemia Drugs Market - Segments
Global anemia drugs market has been segmented on the basis of anemia type which comprises iron deficiency anemia, sickle cell anemia, aplastic anemia, hemolytic anemia pernicious anemia and others. On the basis of route of administration;…
Anemia in Chronic Kidney Disease (Renal Anemia) - Industry Analysis, Trends, and …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Anemia in Chronic Kidney Disease Pipeline Review, H1 2017” to its report offerings. The report provides an overview of the Anemia in Chronic Kidney Disease (Renal Anemia) (Hematological Disorders) pipeline landscape.
Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1196648
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2017,…
